Prot #CP543.2001: A Double-Blind, Randomized, Placebo-Controlled, Parallel Dose Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients with Moderate to Severe Alopecia Areata

Project: Research project

Project Details

StatusFinished
Effective start/end date2/8/17 → 2/8/20

Funding

  • Rho, Inc (Prot #CP543.2001 // Prot #CP543.2001)
  • Concert Pharmaceuticals, Inc. (Prot #CP543.2001 // Prot #CP543.2001)